As prices for prescription drugs have skyrocketed, drugmakers have faced scrutiny from consumer advocates and lawmakers demanding increased transparency and lower costs. Several recent polls show that the issue is on the minds of many U.S. residents, and it will likely play an influential role in the 2016 presidential election season.
American Health Line staff writer Julia Haskins spoke with Bryan Birch -- CEO of prescription drug analytics and technology company Truveris -- to learn more about this complex issue. In part one of the conversation, Birch takes us behind the scenes of drug pricing.
Read Full Article »